• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail

Search Publications



Starting Date

Ending Date

Order by

Entry Details

J Infect Dis 2013 Aug;208(3):413-7

DNA priming prior to H5N1 inactivated influenza vaccination expands antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults.

Khurana S, Wu J, Dimitrova M, King LR, Manischewitz J, Graham BS, Ledgerwood JE, Golding H


DNA priming improves response to inactivated H5N1 vaccination. We assessed the immunogenicity of H5 DNA (A/Indonesia/5/2005) followed by H5N1 monovalent inactivated vaccine (MIV) boost at 4, 8, 12, 16, and 24 weeks compared to two-doses of H5N1 MIV in adults. Antibody epitope repertoires were elucidated by Genome-Fragment-Phage-Display-Library, and antibody avidities for HA1 and HA2 domains were measured by Surface Plasmon Resonance. H5 DNA priming expanded H5-specific antibody epitope repertoire and enhanced antibody avidity to the HA1 (but not HA2) domain, in interval-dependent manner. Enhanced HA1-binding and avidity (=12 wk interval) correlated with improved neutralization of homologous and heterologous H5N1 strains.

Category: Journal Article
PubMed ID: #23633404 DOI: 10.1093/infdis/jit178
Includes FDA Authors from Scientific Area(s): Biologics
Entry Created: 2012-11-28 Entry Last Modified: 2013-08-11